About Realcan Pharmaceutical Group Company

The company was founded on September 21, 2004. The company was listed on the Shenzhen A-share market in June 2011. The sales network covers 31 provinces and cities across the country, directly serving nearly 60,000 medical institutions, and its business covers leading pharmaceutical distribution enterprises of almost all sizes from domestic and foreign manufacturers. The company's main business is the pharmaceutical and device distribution sector, in vitro diagnosis sector, digital medical sector, pharmaceutical logistics sector, and traditional Chinese medicine sector. Corporate honors: China's Top 500 Manufacturing Companies, China's Top 500 Enterprise Credit, China's Top 500 Service Enterprise Credit, Pharmaceutical Logistics Industry, etc., were awarded the Shandong National Economic Mobilization Center, selected as the Shandong Provincial Top 20 Cold Chain Logistics Top 500, China's Top 500 Service Enterprises, “Quality Lu Pharmaceutical” Construction Demonstration Enterprise in Shandong Province, “Cloud Computing Driven Innovation Journey” and “Ruikang Pharmaceutical's One-Click Signing Case” in the National Pharmaceutical Industry Digital Transformation and Innovation Case Collection “Safety Award”; Long Huikang Traditional Chinese Medicine Technology was selected in the “First Batch of Provincial Digital Industry Key Projects List”, becoming the only enterprise in Yantai to be selected as the “2023 Provincial Service Industry Development Guidance Fund Support Platform Enterprise List”.